Therapeutics in Active Prostate Cancer Surveillance

Summary

Testing if short-term use of apalutamide can reduce image defined tumour volumes in men with detectable lesion on multi-parametric Magnetic Resonance Imaging (mpMRI) and being managed by Active Surveillance. The trial will also evaluate the tolerability and side effect profile of men on AS using short term apalutamide and patient acceptability as a therapeutic strategy, as well as determining feasibility of a larger prospective randomised trial of apalutamide.

Timeline

Start

2018-06-05

Primary completion

2019-07-25

Completion

2019-07-25

Drugs

Indications